Pair Name | Gamma-Tocotrienol, Capecitabine | ||
Phytochemical Name | Gamma-Tocotrienol (PubChem CID: 5282349 ) | ||
Anticancer drug Name | Capecitabine (PubChem CID: 60953 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Gamma-Tocotrienol, Capecitabine | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | BIRC2 | hsa329 |
Down-regulation | Expression | BIRC3 | hsa330 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | CXCR4 | hsa7852 | |
Down-regulation | Expression | ICAM1 | hsa3383 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Down-regulation | Expression | MYC | hsa4609 | |
Down-regulation | Expression | NFKB1 | hsa4790 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
In Vivo Model | Luciferase-transfected HCT 116 cells (2×10⁶) in PBS (50 μl) were injected subcutaneously into the leg of each mouse with a 27-gauge needle. | |||
Result | Our findings suggest that γ-T3 inhibited the growth of human CRC and sensitised CRC to capecitabine by regulating proteins linked to tumourigenesis. |
Pair Name | Gamma-Tocotrienol, Capecitabine | |||
Disease Info | [ICD-11: 2B72] | Gastric cancer | Investigative | |
Biological Phenomena | Inhibition-->Angiogenesis | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Down-regulation | Expression | BCL-xL | hsa598 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | COX2 | hsa4513 | |
Down-regulation | Expression | CXCR4 | hsa7852 | |
Down-regulation | Expression | ICAM1 | hsa3383 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Up-regulation | Expression | PARP1 | hsa142 | |
Down-regulation | Expression | RELA | hsa5970 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | SNU-5 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0078 |
SNU-16 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0076 | |
MKN45 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0434 | |
Result | Our results show that γ-tocotrienol can potentiate the effects of capecitabine through suppression of NF-κB-regulated markers of proliferation, invasion, angiogenesis, and metastasis. |
No. | Title | Href |
---|---|---|
1 | γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules. Br J Cancer. 2016 Sep 27;115(7):814-24. doi: 10.1038/bjc.2016.257. | Click |
2 | First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. Clin Cancer Res. 2012 Apr 15;18(8):2220-9. doi: 10.1158/1078-0432.CCR-11-2470. | Click |